Cardiovascular pharmacogenomics. Roden DM, Johnson JA, Kimmel SE, Krauss RM, Medina MW, Shuldiner A, Wilke RA (2011) Circ Res 109: 807-20 Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis. Afshartous D, Bauer SR, Connor MJ, Aduroja OA, Amde M, Salem C, Groszek JJ, Fissell WH (2014) Am J Kidney Dis 63: 170-1 Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative. Nolin TD, Aronoff GR, Fissell WH, Jain L, Madabushi R, Reynolds K, Zhang L, Huang SM, Mehrotra R, Flessner MF, Leypoldt JK, Witcher JW, Zineh I, Archdeacon P, Roy-Chaudhury P, Goldstein SL, Kidney Health Initiative (2015) Clin J Am Soc Nephrol 10: 159-64 Adverse drug events during AKI and its recovery. Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA, Neal EB, Peterson JF (2013) Clin J Am Soc Nephrol 8: 1070-8 Characteristics and effects of nurse dosing over-rides on computer-based intensive insulin therapy protocol performance. Campion TR, May AK, Waitman LR, Ozdas A, Lorenzi NM, Gadd CS (2011) J Am Med Inform Assoc 18: 251-8 Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin. Xu H, Jiang M, Oetjens M, Bowton EA, Ramirez AH, Jeff JM, Basford MA, Pulley JM, Cowan JD, Wang X, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC (2011) J Am Med Inform Assoc 18: 387-91 Antimicrobial dosing in acute renal replacement. Fissell WH (2013) Adv Chronic Kidney Dis 20: 85-93
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.